Lauralyn McIntyre

Contact Information

Lauralyn McIntyre, MD, MHSc, FRCPC
613 737-8899 ext 73231
lmcintyre@ohri.ca

ORCID logo https://orcid.org/0000-0001-7421-1407

Funding

07/2022 - 09/2025
A Training Platform in Pragmatic Registry-Based Trials: Connecting Canada's Health, Data, and Biomanufacturing Sectors
Principals: L. McIntyre, E. Basile, et al.
Funding: Canadian Institute for Health Research Training Grant: Clinical Trials Training Program
Funds Awarded: $3,479,320 & 869,831 (Indirect costs)

07/2022–06/2025
Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock: A Phase II RCT      Principal: L. McIntyre (nominated), A. Fox-Robichaud, D. Fergusson, A. Mendelson, D. Stewart, K. Walley
Funding:  Canadian Institutes of Health Research, Clinical Trials Projects
Funds Awarded: $1,318,714

07/2022–06/2025
Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock: A Phase II RCT 
Principals: L. McIntyre (nominated), A. Fox-Robichaud, D. Fergusson, A. Mendelson, D. Stewart, K. Walley Funding: Canadian Institutes of Health Research, Clinical Trails Projects – Indirect Costs
Funds Awarded: $329,678

04/2022-05/2025
Umbilical Mesenchymal Stem Cells as Cellular Immunotherapy for Septic Shock (UC-CISS): A Phase II RCT  
Principal: L. McIntyre
Funding: Stem Cell Network: Clinical Trials Awards Program
Funds Awarded: $999,850   

02/2021-03/2025 
Derivation and Internal Validation of a Health Administrative Algorithm for Sepsis                                    Principals: L. McIntyre, E. Curley, K. Thavorn
Funding: Ottawa Hospital Academic Medical Organization (The) (TOHAMO), Innovation Project                    Funds Awarded: $50,781